Zobair Younossi
Surgery · Falls Church, VANPI 1194760298
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (46.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Gilead at 49.3% of the total. Reporting peaked in 2019 at $401,676 and has fallen 79.3% since, to $83,191 in 2025. Among surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $6065.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$610K
- Siemens Medical Solutions USA, Inc.$279K
- Intercept Pharmaceuticals, Inc.$118K
- Novo Nordisk AS$113K
- Novo Nordisk$38K
- GSK$15K
- plus $65K from 13 others
Across 41 payments — averaging $100,534 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$3M
- Siemens Medical Solutions USA, Inc.$538K
- GSK$334K
- Merck$248K
What the payments were for
- Royalty or licence$569,50046%
- Consulting fees$361,90929%
- Speaking & faculty fees$257,53521%
- Travel & lodging$44,1624%
- Food & beverage$4,2380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 32 | $610,091 |
| Siemens Medical Solutions USA, Inc. | 53 | $278,848 |
| Intercept Pharmaceuticals, Inc. | 24 | $118,177 |
| Novo Nordisk AS | 21 | $112,540 |
| Novo Nordisk | 16 | $38,234 |
| GSK | 8 | $14,590 |
| Boehringer Ingelheim | 12 | $11,702 |
| Boehringer Ingelheim International GmbH | 10 | $9,143 |
| Ipsen Biopharmaceuticals, Inc | 3 | $9,071 |
| E.r. Squibb & Sons, L.L.C. | 3 | $8,450 |
| Madrigal Pharmaceuticals | 10 | $5,920 |
| AbbVie | 1 | $4,000 |
| Merck | 2 | $3,780 |
| Ipsen Bioscience Inc. | 1 | $3,320 |
| Bausch Health US, LLC | 3 | $2,407 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $2,404 |
| Theratechnologies Inc. | 1 | $2,000 |
| Mallinckrodt Hospital Products Inc. | 1 | $2,000 |
| Dexcom, Inc. | 1 | $665 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADVIA Centaur XP Analyzer$135,939
- Atellica IM 1300 Analyzer$32,099
- ADVIA Chemistry XPT System$17,555
- OCALIVA$7,122
- REZDIFFRA$4,115
- ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization$4,068
- XIFAXAN$2,325
- RESMETIROM$1,600
How this compares
$1,237,344 in reported general payments places this provider in the 95th percentile of 675 surgery providers in Virginia.
Other surgery in Falls Church
- Hiral PatelFalls Church$16K
- Raymond MakhoulRichmond$1.5M
- Yassar YoussefNorfolk$1M
- David WeintrittAlexandria$555K
- Hazem ElarinyVienna$368K
- George GillianLorton$214K
- Joseph GreeneReston$187K
- Lamiere DowningChristiansburg$175K
- Amanda CoxSalem$142K
- Christopher NorthupCharlottesville$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.